These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6663 related articles for article (PubMed ID: 12749752)

  • 1. Gangliosides as therapeutic targets for cancer.
    Fredman P; Hedberg K; Brezicka T
    BioDrugs; 2003; 17(3):155-67. PubMed ID: 12749752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside antigens expressed by human cancer cells.
    Ritter G; Livingston PO
    Semin Cancer Biol; 1991 Dec; 2(6):401-9. PubMed ID: 1810468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting
    Fleurence J; Fougeray S; Bahri M; Cochonneau D; Clémenceau B; Paris F; Heczey A; Birklé S
    J Immunol Res; 2017; 2017():5604891. PubMed ID: 28154831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy.
    Labrada M; Clavell M; Bebelagua Y; León Jd; Alonso DF; Gabri MR; Veloso RC; Vérez V; Fernández LE
    Expert Opin Biol Ther; 2010 Feb; 10(2):153-62. PubMed ID: 20088712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing potential role of gangliosides in immunomodulation and cancer therapeutics.
    Hegde M; Girisa S; Aswani BS; Alqahtani MS; Abbas M; Sethi G; Kunnumakkara AB
    Life Sci; 2024 Aug; 351():122786. PubMed ID: 38848944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy.
    Durrant LG; Noble P; Spendlove I
    Clin Exp Immunol; 2012 Feb; 167(2):206-15. PubMed ID: 22235996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy.
    Groux-Degroote S; Delannoy P
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioside vaccines with emphasis on GM2.
    Livingston P
    Semin Oncol; 1998 Dec; 25(6):636-45. PubMed ID: 9865678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Strategies for Human IgM Antibodies Directed at Tumor-Associated Ganglioside Antigens: Discoveries Made During the Morton Era and Future Directions.
    Jones PC; Irie RF
    Crit Rev Oncog; 2016; 21(1-2):75-81. PubMed ID: 27481004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NGcGM3 ganglioside: a privileged target for cancer vaccines.
    Fernandez LE; Gabri MR; Guthmann MD; Gomez RE; Gold S; Fainboim L; Gomez DE; Alonso DF
    Clin Dev Immunol; 2010; 2010():814397. PubMed ID: 21048926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gangliosides: Structures, Biosynthesis, Analysis, and Roles in Cancer.
    Groux-Degroote S; Guérardel Y; Delannoy P
    Chembiochem; 2017 Jul; 18(13):1146-1154. PubMed ID: 28295942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of gangliosides in active immunotherapy with melanoma vaccine.
    Ravindranath MH; Morton DL
    Int Rev Immunol; 1991; 7(4):303-29. PubMed ID: 1779175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glioma-associated gangliosides 3'-isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains.
    Hedberg KM; Mahesparan R; Read TA; Tysnes BB; Thorsen F; Visted T; Bjerkvig R; Fredman P
    Neuropathol Appl Neurobiol; 2001 Dec; 27(6):451-64. PubMed ID: 11903928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouse.
    El-Abbadi M; Seyfried TN; Yates AJ; Orosz C; Lee MC
    Br J Cancer; 2001 Jul; 85(2):285-92. PubMed ID: 11461091
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Cavdarli S; Delannoy P; Groux-Degroote S
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192217
    [No Abstract]   [Full Text] [Related]  

  • 17. Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.
    Fernández LE; Alonso DF; Gomez DE; Vázquez AM
    Expert Rev Vaccines; 2003 Dec; 2(6):817-23. PubMed ID: 14711364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression analysis of 0-series gangliosides in human cancer cell lines with monoclonal antibodies generated using knockout mice of ganglioside synthase genes.
    Bhuiyan RH; Kondo Y; Yamaguchi T; Tokuda N; Ohkawa Y; Hashimoto N; Ohmi Y; Yamauchi Y; Furukawa K; Okajima T; Furukawa K
    Glycobiology; 2016 Sep; 26(9):984-998. PubMed ID: 27102283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
    Hakomori S
    Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.
    Ravindranath MH; Morton DL; Irie RF
    Cancer Res; 1989 Jul; 49(14):3891-7. PubMed ID: 2472199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 334.